Article
Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Molecular oncology - 1 Sept 2021
Andrés-Zayas Cristina, Suárez-González Julia, Rodríguez-Macías Gabriela, Dorado Nieves, Osorio Santiago, Font Patricia, Carbonell Diego, Chicano María, Muñiz Paula, Bastos Mariana, Kwon Mi, Díez-Martín José Luis, Buño Ismael, Martínez-Laperche Carolina
Abstract excerpt
Myeloid neoplasms (MN) with germline predisposition (MNGP) are likely to be more common than currently appreciated. Many of the genes involved in MNGP are also recurrently mutated in sporadic MN. Therefore, routine analysis of gene panels by next-generation sequencing provides an effective approach to detect germline variants with clinical significance in patients with hematological malignancies. Gene panel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
